Silimed begins its activities in Rio de Janeiro
FOR MORE THAN 40 YEARS CONNECTING SCIENCE AND WELLNESS.
Present in the market since 1978, SILIMED is the largest manufacturer of silicone gel implants in Latin America, it is present in several countries and is the sales leader in the Brazilian market.
For more than 40 years it has contributed to plastic surgery, promoting research, scientific studies and the development of the best technologies, always in collaboration with Plastic Surgeons.
All Silimed products are made with top quality raw materials and state-of-the-art technology, which guarantees all the necessary certifications to operate in different countries.
Silimed plans a future of growth and world leadership in the different markets in which it operates, without losing its essence, by increasingly connecting science and wellness.
Start of the production of silicone implants in Brazil.
Beginning of the export and international market trend.
Start of the distribution in Latin America of polyurethane-coated mammary implants, imported from the United States.
Beginning of a legacy
In 1978, a group of forward-thinking young people decided to combine idealism and an entrepreneurial spirit, investing in the creation of a new business in the Brazilian market. Silimed was born in Rio de Janeiro, a company that had in its DNA the objective of providing health and well-being.
Activities started in Brazil by importing mammary implants from France. Then, in 1981, it began manufacturing its own implants and the following year it began exporting to Argentina. The first 10 years were characterized by important challenges for a Brazilian industry that, in collaboration with the medical class, began to strengthen in its country and in Latin America.
The production of polyurethane-coated mammary implants began and expanded the export of its products to Europe
Start of the production of breast implants with a structured surface developed with our technology
Pioneer in printing the individual serial number of each implant
It obtained the ISO 9002 certification focused on the acquisition of the CE mark. One of the first manufacturers of mammary implants in the world to carry the quality mark
In 1989 it developed its own innovative technology for the production of vulcanized polyurethane foam coated mammary implants. That same year it expanded its market share and began exporting its products to Europe.
It was the first company in the world to identify its products with a unique serial number, guaranteeing control, traceability and security. This was followed by other manufacturers and required as a form of credibility for plastic surgeons, patients, and certification bodies.
Achievement of the CE mark and intensification of exports and sales of products in Europe
Inauguration of the second factory to expand the production area
Relaunch of the exclusive Silimed model of conical implant covered in polyurethane
Launch of the BioDesign Collection, a broad and sophisticated line of mammary implants
GROWTH AND INNOVATION
After two decades of constant growth, it has established itself as a leader in the Brazilian market and as one of the main players worldwide.
To meet the high demand, it built a new factory in 2003, expanding its production capacity and bringing in new technological resources.
In this decade it has invested in two major product innovations. In 2006, it relaunched the mammary implant with a conical design, an exclusive Silimed model to this day. In 2008, it launched a line of breast implants with an exclusive design concept to satisfy different biotypes, the Biodesign Collection, a complete matrix, with 5 formats and up to 4 projections for each base size.
FDA approval, becoming the only non-US manufacturer to receive certification. Gabriel
Robert assumes the position of new CEO of the company
It appears in the Forbes Magazine Investment Guide
Inauguration of the new administrative headquarters in Rio de Janeiro, repositioning of the Silimed brand and resumption of production of other product lines
Silimed 40th anniversary celebration. Opening of international subsidiaries in Mexico and Colombia. Start of construction of the new plant
ACHIEVEMENTS AND NEW CHALLENGES
The beginning of this decade was marked by the great achievement of being the first non-US implant manufacturer to receive FDA approval.
In the same decade, the group of young people who started this great company restructured Silimed's leadership and, without losing its essence and brand value, chose a family member, Gabriel Robert, to lead the company as CEO. A new, more dynamic and future-oriented management model is applied. This group is now part of the board of directors.
At the age of forty, a new cycle of challenges has begun, with the opening of international subsidiaries, the construction of a new factory and the search for technological innovations.
Regained the CE Mark for Mammary Implants.
Inaugurated the New Factory.
Returned to Europe.
It opened new international branches in Italy, Korea and Peru.
INAUGURATION OF THE NEW FACTORY
2020 - 2021
Regained the CE Mark for mammary implants. Inaugurated the new factory. Returned to Europe. It opened new international branches in Italy, Korea and Peru.